Related Experiment Video
Updated: Mar 1, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest
Derek B Hoyme1, Sonali S Patel2, Ricardo A Samson3
1Stead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, IA, United States.
Insights
Longer epinephrine dosing intervals during pediatric in-hospital cardiac arrest (IHCA) are linked to better survival rates. This finding challenges current guidelines recommending shorter intervals for improved outcomes in children.
Area of Science:
- Pediatric critical care medicine
- Cardiopulmonary resuscitation research
- Clinical trial methodology
Background:
- Current guidelines suggest epinephrine administration every 3-5 minutes during cardiopulmonary resuscitation.
- Previous studies in adults with in-hospital cardiac arrest (IHCA) indicate that longer epinephrine dosing intervals correlate with improved survival to discharge.
- The efficacy of extended epinephrine dosing intervals in pediatric IHCA remains to be fully elucidated.
Purpose of the Study:
- To investigate the association between longer epinephrine dosing intervals and survival to hospital discharge in pediatric patients experiencing in-hospital cardiac arrest (IHCA).
- To evaluate if extending epinephrine dosing intervals beyond current recommendations impacts survival outcomes in pediatric IHCA cases.
Main Methods:
- A retrospective analysis was conducted using the AHA Get With The Guidelines-Resuscitation registry, including 1630 pediatric IHCAs.
- Epinephrine dosing intervals were calculated by dividing the resuscitation duration by the number of doses administered, categorized into 1-5 min, >5 to <8 min, and 8 to <10 min per dose.
- Multivariable logistic regression models were employed to control for various confounding factors, with a secondary analysis stratifying patients based on vasoactive infusion status at the time of arrest.
Main Results:
- For the overall cohort, adjusted odds ratios for survival to hospital discharge were 1.81 (95% CI 1.26-2.59) for >5 to <8 min intervals and 2.64 (95% CI 1.53-4.55) for 8 to <10 min intervals, compared to the 1-5 min reference.
- In patients not receiving vasoactive infusions, adjusted odds ratios for survival were 1.99 (95% CI 1.29-3.06) for >5 to <8 min intervals and 2.67 (95% CI 1.14-5.04) for 8 to <10 min intervals.
- These results indicate a statistically significant association between longer epinephrine dosing intervals and improved survival rates.
Conclusions:
- Longer average epinephrine dosing intervals during pediatric in-hospital cardiac arrest (IHCA) are associated with enhanced survival to hospital discharge.
- The findings suggest a potential need to re-evaluate current epinephrine administration guidelines for pediatric IHCA.
- Extended epinephrine dosing intervals may represent a viable strategy to improve outcomes in pediatric cardiac arrest resuscitation.
Background:
Current guidelines recommend epinephrine every 3-5min during cardiopulmonary resuscitation. For adults with in-hospital cardiac arrest (IHCA), longer dosing intervals are associated with improved survival to discharge. This study investigates whether longer epinephrine dosing intervals were associated with improved survival to discharge during pediatric IHCA.
Methods:
Retrospective review of AHA Get With The Guidelines-Resuscitation registry identified 1630 pediatric IHCAs that met inclusion criteria. Average epinephrine dosing interval was defined by dividing duration of resuscitation after first dose of epinephrine by total doses. Average dosing intervals were categorized as 1-5min, >5 to <8min, and 8 to <10min/dose. Primary outcome was survival to hospital discharge. Multivariable logistic regression models controlled for age, gender, illness category, location of arrest, arrest duration, time of day, and time to first epinephrine dose. Secondary analysis separated patients on vasoactive infusion at the time of arrest from those without an infusion in place.
Results:
Odds ratios (OR) calculated using 1-5min/dose interval as reference. For the total cohort, adjusted OR for survival to hospital discharge for >5 to <8min was 1.81 (95% CI 1.26-2.59), and 8 to <10min 2.64 (95% CI 1.53-4.55). For patients not receiving vasoactive infusion, adjusted OR for survival to discharge for >5 to <8min was 1.99 (95% CI 1.29-3.06) and 8 to <10min 2.67 (95% CI 1.14-5.04).
Conclusions:
Longer average dosing intervals than currently recommended for epinephrine administration during pediatric IHCA were associated with improved survival to hospital discharge.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Drug Dosing: Infants and Children
Acute Coronary Syndrome IV: Interprofessional Care

